{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:56:16Z","timestamp":1777560976809,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.bbrc.2013.04.113","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T01:36:23Z","timestamp":1371087383000},"page":"645-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Amlodipine prevents apoptotic cell death by correction of elevated intracellular calcium in a primary neuronal model of Batten disease (CLN3 disease)"],"prefix":"10.1016","volume":"436","author":[{"given":"Ashley","family":"Warnock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"an Haack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas B.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.04.113_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","article-title":"The neuronal ceroid-lipofuscinoses","volume":"62","author":"Haltia","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbrc.2013.04.113_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.2004.tb00499.x","article-title":"Current state of clinical and morphological features in human NCL","volume":"14","author":"Goebel","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbrc.2013.04.113_b0015","unstructured":"S.E. Mole, R.E. Williams, Neuronal Ceroid-Lipofuscinoses, GeneReviews. <http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1428\/>, updated 2010 (accessed 24.04.2013)."},{"key":"10.1016\/j.bbrc.2013.04.113_b0020","first-page":"241","article-title":"Mutations in DNAJC5, encoding cysteine-string protein alpha cause autosomal dominant adult-onset neuronal ceroid lipofuscinosis","volume":"89","author":"Noskova","year":"2011","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2013.04.113_b0025","unstructured":"NCL database. <http:\/\/www.ucl.ac.uk\/ncl\/mutation.shtml> (accessed 24.04.2013)."},{"key":"10.1016\/j.bbrc.2013.04.113_b0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jnr.20367","article-title":"CLN3, the protein associated with Batten disease: structure, function and localization","volume":"79","author":"Phillips","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrc.2013.04.113_b0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2008.01.001","article-title":"The function of CLN3P, the Batten disease protein","volume":"93","author":"Rakheja","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2013.04.113_b0040","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bbrc.2004.03.146","article-title":"CLN3P, the Batten disease protein, localizes to membrane lipid rafts (detergent-resistant membranes)","volume":"317","author":"Rakheja","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2013.04.113_b0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.20975","article-title":"CLN3P, the Batten disease protein, is a novel palmitoyl-protein-9 desaturase","volume":"60","author":"Narayan","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2013.04.113_b0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1471-4159.1996.67020677.x","article-title":"Apoptosis as the mechanism of neurodegeneration in Batten\u2019s disease","volume":"67","author":"Lane","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.04.113_b0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/mgme.1999.2834","article-title":"CLN3 defines a novel apoptotic pathway operative in neurodegeneration and mediated by ceramide","volume":"66","author":"Puranam","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2013.04.113_b0060","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.10143","article-title":"Flupirtine blocks apoptosis in batten lymphoblasts and human postmitotic CLN3- and CLN2-deficient neurons","volume":"51","author":"Dhar","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2013.04.113_b0065","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/hmg\/11.18.2129","article-title":"Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis","volume":"11","author":"Persaud-Sawin","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2013.04.113_b0070","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10495-005-0733-6","article-title":"Cell death pathways in juvenile Batten disease","volume":"10","author":"Persaud-Sawin","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2013.04.113_b0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2006.01.011","article-title":"Over-expression of CLN3P, the Batten disease protein, inhibits PANDER-induced apoptosis in neuroblastoma cells: further evidence that CLN3P has anti-apoptotic properties","volume":"88","author":"Narayan","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2013.04.113_b0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/hmg\/ddl466","article-title":"Neuronal vulnerability of CLN3 deletion to calcium-induced cytotoxicity is mediated by calsenilin","volume":"16","author":"Chang","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2013.04.113_b0085","first-page":"186","article-title":"Screening for calcium channel modulators in CLN3 siRNA knock down SH-SY5Y neuroblastoma cells reveals a significant decrease of intracellular calcium levels by selected L-type calcium channel blockers","volume":"2011","author":"an Haack","year":"1810","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2013.04.113_b0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/syn.890180206","article-title":"Properties of inhibitory and excitatory synapses between hippocampal neurons in very low density cultures","volume":"18","author":"Wilcox","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.bbrc.2013.04.113_b0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0361-9230(91)90003-3","article-title":"Electrophysiological comparison of pyramidal and stellate, non-pyramidal neurons in dissociated hippocampal cell cultures of rat hippocampus","volume":"26","author":"Buchhalter","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbrc.2013.04.113_b0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.20975","article-title":"CLN3P, the Batten\u2019s disease protein, is a novel palmitoyl-protein delta-9 desaturase","volume":"60","author":"Narayan","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2013.04.113_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/MB:14:3:197","article-title":"A flow cytometric protocol for titering recombinant adenoviral vector containing the green fluorescent protein","volume":"14","author":"Hitt","year":"2000","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.bbrc.2013.04.113_b0110","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/diabetes.48.8.1535","article-title":"Glucose regulation of glutaminolysis and its role in insulin secretion","volume":"48","author":"Gao","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2013.04.113_b0115","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1074\/jbc.M600994200","article-title":"Effects of a GTP-insensitive mutation of glutamate dehydrogenase on insulin secretion in transgenic mice","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.04.113_b0120","doi-asserted-by":"crossref","first-page":"31806","DOI":"10.1074\/jbc.M110.123638","article-title":"Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase","volume":"285","author":"Li","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.04.113_b0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/mgme.1999.2830","article-title":"Tissue expression and subcellular localization of CLN3, the Batten disease protein","volume":"66","author":"Margraf","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2013.04.113_b0130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/hmg\/9.5.735","article-title":"Evaluation of CLN3 mutations on protein traficking and function","volume":"9","author":"Haskell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2013.04.113_b0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1100\/tsw.2010.82","article-title":"Autophagy regulates the post-translational cleavage of BCL-2 and promotes neuronal survival","volume":"18","author":"Lossi","year":"2010","journal-title":"ScientificWorldJ."},{"key":"10.1016\/j.bbrc.2013.04.113_b0140","doi-asserted-by":"crossref","first-page":"20483","DOI":"10.1074\/jbc.M602180200","article-title":"Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"281","author":"Cao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.04.113_b0145","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1046\/j.1471-4159.1999.721448.x","article-title":"Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells","volume":"72","author":"Mason","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.04.113_b0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1291\/hypres.27.271","article-title":"Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats","volume":"27","author":"Yamagata","year":"2004","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbrc.2013.04.113_b0155","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1471-4159.2011.07529.x","article-title":"Amlodipine besylate and amlodipine camsylate prevent cortical neuronal cell death induced by oxidative stress","volume":"119","author":"Lee","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.04.113_b0160","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0022-3565(24)35127-4","article-title":"Selectivities of dihydropyridine derivatives in blocking Ca (2+) channel subtypes expressed in xenopus oocytes","volume":"291","author":"Furukawa","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2013.04.113_b0165","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jnr.21015","article-title":"Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments","volume":"84","author":"Luiro","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrc.2013.04.113_b0170","first-page":"743","article-title":"Amlodipine attenuates oxidative stress-induced hypertension","volume":"17","author":"Ganafa","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2013.04.113_b0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjhyper.2003.09.007","article-title":"Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats","volume":"17","author":"Zhou","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbrc.2013.04.113_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1291\/hypres.29.49","article-title":"Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats","volume":"29","author":"Hirooka","year":"2006","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbrc.2013.04.113_b0185","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/ddr088","article-title":"The Batten disease gene CLN3 is required for the response to oxidative stress","volume":"20","author":"Tuxworth","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2013.04.113_b0190","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0024-3205(97)00881-3","article-title":"Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists","volume":"21","author":"Uchida","year":"1997","journal-title":"Life Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13009650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13009650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T12:10:20Z","timestamp":1746015020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13009650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0006291X13009650"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.04.113","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amlodipine prevents apoptotic cell death by correction of elevated intracellular calcium in a primary neuronal model of Batten disease (CLN3 disease)","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.04.113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}